Amplified genes had been cloned in to the TA vector (RBC Bioscience, Taiwan) and sequenced
Amplified genes had been cloned in to the TA vector (RBC Bioscience, Taiwan) and sequenced. of hemagglutination inhibition (HI) antibody…
The average decrease of the three biomarkers with a threshold of 10% appears to be the best parameter to distinguish patients with progressive disease from other patients
The average decrease of the three biomarkers with a threshold of 10% appears to be the best parameter to distinguish…
Using an antibody (DB308) directed against a central region of dystrobrevin, we purified complexes and found that both 1- and 1-syntrophins and 71C74 dystrophin copurified with dystrobrevin (Fig
Using an antibody (DB308) directed against a central region of dystrobrevin, we purified complexes and found that both 1- and…
C, Ves v 5 (nonsensitized, n = 89; sensitized, n = 10)
C, Ves v 5 (nonsensitized, n = 89; sensitized, n = 10). to microarrayed allergens had been driven at 5…
Furthermore, in 2 baboons (B3907, “type”:”entrez-nucleotide”,”attrs”:”text”:”B18308″,”term_id”:”2316212″,”term_text”:”B18308″B18308) complement activity was eliminated by the administration of CVF (evidenced by the CH50 test, data not shown), and in 4 baboons the grafts were protected from complement activity by the over-expression of a human complement-regulatory protein (CD46), yet CC still developed
Furthermore, in 2 baboons (B3907, “type”:”entrez-nucleotide”,”attrs”:”text”:”B18308″,”term_id”:”2316212″,”term_text”:”B18308″B18308) complement activity was eliminated by the administration of CVF (evidenced by the CH50 test,…
When feasible, clean tumor biopsies were collected just before and during treatment for the analysis of pharmacodynamics, including in depth genomic analysis
When feasible, clean tumor biopsies were collected just before and during treatment for the analysis of pharmacodynamics, including in depth…
Frank
Frank. randomized, double-blind, placebo-controlled stage?2 research (no. “type”:”clinical-trial”,”attrs”:”text”:”NCT02481674″,”term_id”:”NCT02481674″NCT02481674) established to judge pepinemab, a semaphorin?4D (SEMA4D)-blocking antibody, for treatment of Huntingtons…